Know our techniques


BRCA 1/2 · BREAST CANCER GENETIC TEST

Early and personalized detection of breast cancer.

A woman's risk of developing breast or ovarian cancer is greatly increased if she inherits a harmful mutation in BRCA1 or BRCA 2. The test is carried out with a simple blood analysis and allows, in the event of a positive result, a follow-up and / or early and personalized detection measures, for the patient and her family members. This test helps counseling the couple in a right way before an assisted reproduction treatment.



Products of Conception(POC)

Studies of fetal remains by array Comparative Genomic Hybridization (aCGH). 50% of miscarriages in the first trimester of pregnancy are due to chromosomal abnormalities. The aCGH is a molecular technique that allows direct analysis of aneuploidy on 24 chromosomes. The study of markers in maternal blood can rule out misdiagnosis for possible maternal contamination.

Results in a week, 98.6% accuracy, does not require culture. Higher resolution than conventional karyotype test.


Endometrial Receptivity Analysis (ERA)

It allows to evaluate the status of endometrial receptivity to prevent implantation failure.

It is a diagnostic method, that identifies the window of implantation and allows personalized embryo transfer with a timing based on the results. 24% of patients are unreceptive, and in 88% of these cases, a 2nd biopsy determines the window of implantation and therefore, the period in which the patient is receptive. Indicated in women with implantation failure with good quality embryos.


Sperm Aneuploidy Test(SAT)

It'ss a diagnostic test to check male infertility. In couples with a male factor underlying, the risk of transmitting chromosomal abnormalities to offspring from the sperm increases. It allows to evaluate the presence of alterations in the number of chromosomes (aneuploidies and diploidies) in the sperm. It helps counseling the couple before an assisted reproduction treatment.




Preimplantation Genetic Testing for Monogenic diseases (PGT-M)

Early genetic diagnosis performed on the embryo before the transfer for couples with monogenic diseases in their family record or in their personal record. The previous analysis of DNA from each embryo enables selecting and transferring those who doesn't have an inherited disease. PGD can be performed for any monogenic disease. There is a panel of common diseases available whose diagnosis is immediate. It's possible to perform PGT-M + PGT-A in the same biopsy.


Preimplantation Genetic Testing for Aneuploidy (PGT-A)

It is an embryonic genetic analysis that is performed during IVF treatment to detect abnormalities in the chromosomes number. Our technology, based on aCGH, allows to study the 24 chromosomes to rule out embryonic aneuploidies before the embryo transfer. The test accords a higher rate of implantation and pregnancy with a larger number of informative embryos (98%), using a single embryonic cell. Suitable for women of advanced maternal age, recurrent implantation failure, repeated miscarriage and for those couples with a male factor issue.

Carrier Genetic Test (CGT)

It allows to determine the risk of having a child with a genetic disease by analyzing 40,000 DNA variants and more than 600 genetic diseases. It's also performed on sperms or eggs that are meant to be donated. It also includes the most common monogenic diseases analysis, such as cystic fibrosis, spinal muscular atrophy, X-Fragil Beta thalassemia, etc.


Contact our specialists   Schedule your appointment


IREGA - Clinica de Reproduccion Asistida en Acapulco

IREGA is home to a team of experts in the care of fertility, willing to make your dream of having a baby come true.

Social Media

   

IREGA


IREGA ACAPULCO

IREGA CANCÚN

IREGA PUEBLA

USA & CANADA

  • USA 011 52 (744) 484 4471
  • USA 011 52 (744) 488 11 14
  • CANADA 01 52 (744) 484 4471
  • adanoliveros52@gmail.com.mx